Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
Despite the U.S.-Iran ceasefire agreement, the Persian Gulf has seen on-again, off-again fighting as both sides try to assert control...
Publix is one of the largest grocery chains in the country with over 1,400 locations and $60 billion in revenue,...
Oil prices have retreated as the U.S.-Iran war recedes, despite occasional skirmishes, but inflationary trends will continue to apply pressure...
A lender dispute over millions of dollars has led a Hardee's restaurant franchisee to file for bankruptcy to invoke an...
If you've ever shopped at Dollar Tree before, you know that it can sometimes be a frustrating experience. It's sort...
There’s a version of American manhood that used to run on a simple script: leave home, get a job, build...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
